|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Shareholder L. E. Simmons sells 561,422 shares of CPX.
Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.
Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.
Several small-cap stocks were moving on above-average volume during Tuesday's session
Your quick-and-dirty guide to key dates and events for biotech investors during November.
Your quick-and-dirty guide to upcoming phase III clinical trials.
Readers write in about Oncothyreon, Progenics, Chelsea Therapeutics and more.
More work needs to be done before penciling in approval.
Risk-reward for this beaten-down stock improves as pivotal study results loom.
Chelsea Therapeutics should trade sharply higher Thursday on heavy volume after the biotech company offered good news on its Droxidopa drug.
Chelsea Therapeutics says its hypotension drug failed, sending shares on a 61% free fall on Thursday.
Readers weigh in on Chelsea's rheumatoid arthritis duo, Generex's diabetes spray, AMAG's stock dip, and Anadys' prospects.
Investors are selling biotech stocks owned by two hedge funds that took highly concentrated positions in Sequenom on fears that they may be forced to liquidate their other holdings.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.